| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.29 | 1e-08 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.17 | 1e-05 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.24 | 3e-05 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.22 | 3e-05 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.21 | 0.0001 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.15 | 0.0001 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |